Primary Cutaneous Anaplastic Large Cell Lymphoma of the Oral Cavity Successfully Treated with Brentuximab Vedotin.
Federico MeconiRoberto SecchiRaffaele PalmieriSara VaccariniVito Mario RapisardaLaura GiannìFabiana EspositoIda ProvenzanoDaniela NassoLivio PupoMaria CantonettiPublished in: Case reports in hematology (2019)
Primary cutaneous anaplastic large cell lymphoma is a CD-30 positive lymphoproliferative disorder with good prognosis, usually treated with radiation therapy and surgery. Head, neck, and extremities are the most frequently involved sites. In this paper, we describe an unusual case of oral localization, recurring after skin-involving radiotherapy, successfully treated with sixteen cycles of brentuximab vedotin. This could be a more effective approach with a less detrimental toll for treating these rare disorders.
Keyphrases
- hodgkin lymphoma
- radiation therapy
- single cell
- diffuse large b cell lymphoma
- cell therapy
- minimally invasive
- early stage
- epstein barr virus
- locally advanced
- radiation induced
- stem cells
- coronary artery bypass
- coronary artery disease
- mesenchymal stem cells
- bone marrow
- percutaneous coronary intervention
- acute coronary syndrome